Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-26.81	66.54	90.91
Graham Fair Price	22.30	3.27	2.68
PEG	-13.68	0.24	-0.28
Price/Book	-8.86	0.69	0.76
Price/Cash Flow	47.43	9.24	-6.27
Prices/Earnings	-42.19	12.84	22.21
Price/Sales	-21.88	2.49	3.19
Price/FCF	47.43	9.24	-6.27
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-14.72	0.14	0.17
Operating Margin	-3.65	0.06	0.06
ROA	52.53	< 0.005	< 0.005
ROE	< 0.005	0.01	57.65
ROIC	< 0.005	< 0.005	14.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.13	0.29	-54.32
Dividends QOQ	-0.26	-0.27	-6.60
EBIT QOQ	-0.62	0.09	-84.71
EPS QOQ	-0.80	0.54	-33.03
FCF QOQ	-1.32	1.60	21.44
Revenue QOQ	-0.71	0.14	-80.82
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1048.10	917.06	-12.50
Days Sales Outstanding (DSO)	650.51	581.78	-10.57
Inventory Turnover	0.09	0.10	14.29
Debt/Capitalization	0.64	0.67	5.45
Quick Ratio	0.68	0.71	4.20
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	6.11	6.24	2.10
Cash	5.03	5.59	11.15
Capex	-0.03	0.01	-56.73
Free Cash Flow	-0.74	0.44	-39.79
Revenue	1.45	1.65	13.63
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.34	1.33	-0.37
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	50.74	41.33	-18.55
Naive Interpretation	Member

06 - Financial Health · Weak

Rating